| Title | Drugs - Real World Outcomes |
| Abbreviation | Drugs - Real World Outcomes |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (medical) (Q2) |
| h-index | 21 |
| Overall Rank/Ranking | 9571 |
| SCImago Journal Rank (SJR) | 0.564 |
| Impact Score | 2.16 |
| Publisher | Springer International Publishing AG |
| Country | Switzerland |
| ISSN | 21991154, 21989788 |
| Best Quartile | Q2 |
| Coverage History | 2014-2023 |
Drugs - Real World Outcomes is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q2). It is published by Springer International Publishing AG. The overall rank of Drugs - Real World Outcomes is 9571. According to SCImago Journal Rank (SJR), this journal is ranked 0.564. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 21. The best quartile for this journal is Q2.
The ISSN of Drugs - Real World Outcomes journal is 21991154, 21989788. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drugs - Real World Outcomes is cited by a total of 336 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Drugs - Real World Outcomes is 2.16, which is computed in 2024 as per its definition. Drugs - Real World Outcomes IF is increased by a factor of 0.28 and approximate percentage change is 14.89% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Drugs - Real World Outcomes is 2.16. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.16 |
| 2022 | 1.88 |
| 2021 | 2.02 |
| 2020 | 1.81 |
| 2019 | 1.66 |
| 2018 | 1.91 |
| 2017 | 1.03 |
| 2016 | 0.58 |
| 2015 | 0.00 |
| 2014 | 0.00 |
Drugs - Real World Outcomes has an h-index of 21. It means 21 articles of this journal have more than 21 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Drugs - Real World Outcomes is 21991154, 21989788. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Drugs - Real World Outcomes is 9571. According to SCImago Journal Rank (SJR), this journal is ranked 0.564. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.564 |
| 2022 | 0.564 |
| 2021 | 0.532 |
| 2020 | 0.430 |
| 2019 | 0.559 |
| 2018 | 0.564 |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 9571 |
| 2022 | 9180 |
| 2021 | 9399 |
| 2020 | 11419 |
| 2019 | 8863 |
| 2018 | 8518 |
| 2017 | 32950 |
| 2016 | 32672 |
| 2015 | 32323 |
| 2014 | 31713 |
Drugs - Real World Outcomes is published by Springer International Publishing AG. It's publishing house is located in Switzerland. Coverage history of this journal is as following: 2014-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Drugs - Real World Outcomes is Drugs - Real World Outcomes. This abbreviation ('Drugs - Real World Outcomes') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Drugs - Real World Outcomes latest impact IF is 2.16. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 2.16 (2023) and 0.00 (2015), respectively, in the last 10 years. Moreover, its average IS is 1.31 in the previous 10 years.
The Drugs - Real World Outcomes has an SJR (SCImago Journal Rank) of 0.564, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.564 in 2023 and the lowest being in 2017. Furthermore, the average SJR of the Drugs - Real World Outcomes over the previous 10-year period stands at 1.31.
The latest h-index of the Drugs - Real World Outcomes is 21.
The Drugs - Real World Outcomes is published by the Springer International Publishing AG, with its country of publication being the Switzerland.
The Drugs - Real World Outcomes is currently ranked 9571 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 8518 in 2018 and its lowest position of 32950 in 2017.
The standard ISO4 abbreviation for the Drugs - Real World Outcomes is Drugs - Real World Outcomes.
Drugs - Real World Outcomes is classified as a journal that the Springer International Publishing AG publishes.
The Drugs - Real World Outcomes encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Drugs - Real World Outcomes is assigned the following International Standard Serial Numbers (ISSN): 21991154, 21989788.
The best quartile for the Drugs - Real World Outcomes is Q2 (2023).
The Drugs - Real World Outcomes coverage history can be summarized as follows: 2014-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| European Union Politics | journal | 2569 | SAGE Publications Ltd | 75 | 3.24 |
| Qualitative Research | journal | 1588 | SAGE Publications Ltd | 93 | 4.87 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| World Englishes | journal | 3418 | Wiley-Blackwell | 64 | 1.64 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 16153 | Taylor and Francis Ltd. | 25 | 1.10 |
| Palaeontographica Abteilung B: Palaeophytologie | book series | 10391 | E. Schweizerbart'sche Verlagsbuchhandlung | 17 | 3.43 |
| Brazilian Symposium of Computer Graphic and Image Processing | conference and proceedings | 16004 | 32 | 0.00 | |
| Contemporanea | journal | 24588 | Societa Editrice Il Mulino | 6 | 0.25 |
| Physica Status Solidi - Rapid Research Letters | journal | 8109 | Wiley-VCH Verlag | 79 | 2.55 |
| Society and Economy | journal | 17871 | Akademiai Kiado | 16 | 0.87 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.16 |
| 2022 | 1.88 |
| 2021 | 2.02 |
| 2020 | 1.81 |
| 2019 | 1.66 |
| 2018 | 1.91 |
| 2017 | 1.03 |
| 2016 | 0.58 |
| 2015 | 0.00 |
| 2014 | 0.00 |
